Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $2 | $2 |
| % Growth | -27.2% | 10.7% | -3.3% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 41.4% | 60.3% | 59.5% | 61.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | $0 | $0 | $1 |
| % Margin | -29% | 14.5% | 21.1% | 31% |
| Other Income/Exp. Net | $1 | -$0 | $0 | $0 |
| Pre-Tax Income | $1 | $0 | $0 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 29.5% | 7.5% | 15.8% | 22.9% |
| EPS | 0.64 | 0.23 | 0.43 | 0.65 |
| % Growth | 178.3% | -46.5% | -33.8% | – |
| EPS Diluted | 0.64 | 0.23 | 0.43 | 0.65 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $0 | $0 | $1 |
| % Margin | 51.1% | 20.9% | 27.3% | 36.8% |